...
首页> 外文期刊>臨床血液 >Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia
【24h】

Severe hyponatremia with consciousness disturbance caused by hydroxyurea in a patient with chronic myeloid leukemia

机译:严重的低钠血症,具有羟基脲患者患者慢性髓性白血病患者引起的意识障碍

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 79-year-old man was admitted because of consciousness disturbance on August 9, 2002. He had been diagnosed as having chronic myeloid leukemia in 1999, and since then, he had continued to take hydroxyurea (1500 mg/day) orally. On admission, his serum sodium concentration was as low as 119 mEq/L, while urinary sodium excretion was high. Based on the blood picture and lack of hepatosplenomegaly, we considered that the leukemia was still in the chronic phase. Because of normal blood level of the antidiuretic hormone (ADH) concentration and sufficient urine volume, the syndrome of inappropriate ADH secretion (SIADH) was unlikely, and sodium-losing nephropathy was suspected. After discontinuation of hydroxyurea, the urinary sodium excretion decreased and the patient's consciousness became clear concomitantly with improvement in the serum Na level. This patient appears to be the first case of hyponatremia caused by hydroxyurea.
机译:由于2002年8月9日,一名79岁的男子被录取。1999年,他被诊断为患有慢性骨髓白血病,从那时起,他继续服用羟基脲(1500毫克/天)口服。 入学时,他的血清钠浓度低至119meq / L,而尿钠排泄率高。 基于血迹和缺乏肝肺肿大,我们认为白血病仍在慢性阶段。 由于抗性激素的正常血液水平(ADH)浓度和足够的尿量,不太可能的副分泌(SIADH)的综合征不太可能,并且怀疑钠肾病患者。 在停止羟基脲后,尿钠排泄减少,患者的意识伴随着血清NA水平的改善。 该患者似乎是羟基脲引起的解冻血症的第一种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号